Phosphorylated SARM1 is involved in the pathological process of rotenone-induced neurodegeneration
The Journal of Biochemistry · 2023
DOI: 10.1093/jb/mvad068 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Biochemistry, 2023. Verfasst von Hitoshi Murata und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayam…. Hauptthemen laut MEDLINE: Rotenone, Parkinson Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Sterile alpha and Toll/interleukin receptor motif-containing protein 1 (SARM1) is a NAD+ hydrolase that plays a key role in axonal degeneration and neuronal cell death. We reported that c-Jun N-terminal kinase (JNK) activates SARM1 through phosphorylation at Ser-548. The importance of SARM1 phosphorylation in the pathological process of Parkinson’s disease (PD) has not been determined. We thus conducted the present study by using rotenone (an inducer of PD-like pathology) and neurons derived from induced pluripotent stem cells (iPSCs) from healthy donors and a patient with familial PD PARK2 (FPD2). The results showed that compared to the healthy neurons, FPD2 neurons were more vulnerable to rotenone-induced stress and had higher levels of SARM1 phosphorylation. Similar cellular events were obtained when we used PARK2-knockdown neurons derived from healthy donor iPSCs. These events in both types of PD-model neurons were suppressed in neurons treated with JNK inhibitors, Ca2+-signal inhibitors, or by a SARM1-knockdown procedure. The degenerative events were enhanced in neurons overexpressing wild-type SARM1 and conversely suppressed in neurons overexpressing the SARM1-S548A mutant. We also detected elevated SARM1 phosphorylation in the midbrain of PD-model mice. The results indicate that phosphorylated SARM1 plays an important role in the pathological process of rotenone-induced neurodegeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.
- Department of Medical Neurobiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.
- Department of Translational Research and Drug Development, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.
Förderung
- JSPS KAKENHI
Zitieren
APA
Murata, H., Phoo, M. T. Z., Ochi, T., Tomonobu, N., Yamamoto, K. I., Kinoshita, R., Miyazaki, I., Nishibori, M., Asanuma, M., & Sakaguchi, M. (2023). Phosphorylated SARM1 is involved in the pathological process of rotenone-induced neurodegeneration. The Journal of Biochemistry. https://doi.org/10.1093/jb/mvad068
Vancouver
Murata H, Phoo MTZ, Ochi T, Tomonobu N, Yamamoto KI, Kinoshita R, et al. Phosphorylated SARM1 is involved in the pathological process of rotenone-induced neurodegeneration. The Journal of Biochemistry. 2023. doi:10.1093/jb/mvad068
BibTeX
@article{Murata2023,
author = {Murata, Hitoshi and Phoo, May Tha Zin and Ochi, Toshiki and Tomonobu, Nahoko and Yamamoto, Ken-Ichi and Kinoshita, Rie and Miyazaki, Ikuko and Nishibori, Masahiro and Asanuma, Masato and Sakaguchi, Masakiyo},
title = {Phosphorylated SARM1 is involved in the pathological process of rotenone-induced neurodegeneration},
journal = {The Journal of Biochemistry},
year = {2023},
doi = {10.1093/jb/mvad068}
}
EUVIMED